Literature DB >> 10583232

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

D Puthier1, S Derenne, S Barillé, P Moreau, J L Harousseau, R Bataille, M Amiot.   

Abstract

Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells accumulate within the bone marrow. The expression of several anti-apoptotic proteins was evaluated by immunoblotting in human myeloma cell lines and in highly purified native myeloma cells. Expression of Bcl-xL, Mcl-1 and Bcl-2 was found in most of the samples; expression of Bcl-xL and Mcl-1 seemed to be related on myeloma cells. In a system of apoptosis by growth factor deprivation on myeloma cells, we showed that the effect of Bcl-2 seemed minimal whereas Mcl-1 and Bcl-xL were tightly regulated by interleukin (IL)-6. These findings underline the important role of Mcl-1 and Bcl-xL instead of Bcl-2 in IL-6-induced survival of myeloma cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583232     DOI: 10.1046/j.1365-2141.1999.01705.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  40 in total

1.  Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome.

Authors:  Rodger E Tiedemann; Yuan Xao Zhu; Jessica Schmidt; Chang Xin Shi; Chris Sereduk; Hongwei Yin; Spyro Mousses; A Keith Stewart
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

Review 2.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

3.  Bcl-xl expression in multiple myeloma.

Authors:  S D P W M Peeters; S Hovenga; S Rosati; E Vellenga
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.

Authors:  Michel Jourdan; Thierry Reme; Hartmut Goldschmidt; Geneviève Fiol; Véronique Pantesco; John De Vos; Jean-François Rossi; Dirk Hose; Bernard Klein
Journal:  Br J Haematol       Date:  2009-01-08       Impact factor: 6.998

5.  Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma.

Authors:  Vikas A Gupta; Shannon M Matulis; Jason E Conage-Pough; Ajay K Nooka; Jonathan L Kaufman; Sagar Lonial; Lawrence H Boise
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

6.  R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.

Authors:  Michael P Kline; S Vincent Rajkumar; Michael M Timm; Teresa K Kimlinger; Jessica L Haug; John A Lust; Philip R Greipp; Shaji Kumar
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

Review 7.  Recent advances in antimultiple myeloma drug development.

Authors:  Nuozhou Wang; Patrick Bartlow; Qin Ouyang; Xiang-Qun Xie
Journal:  Pharm Pat Anal       Date:  2014-05

Review 8.  Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma.

Authors:  Quan Chen; Subrata Ray; Mohamad A Hussein; Gordan Srkalovic; Alexandru Almasan
Journal:  Leuk Lymphoma       Date:  2003-07

9.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Authors:  Wan Cheung Cheung; Joong Su Kim; Michael Linden; Liangping Peng; Brian Van Ness; Roberto D Polakiewicz; Siegfried Janz
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke.

Authors:  Sabina Halappanavar; Marsha Russell; Martin R Stampfli; Andrew Williams; Carole L Yauk
Journal:  BMC Med Genomics       Date:  2009-08-21       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.